Zusammenfassung
Die Transplantation muskuloskelettalen Gewebes dient der Behandlung ausgedehnter Defekte des muskuloskelettalen Systems, v. a. bei Prothesenwechseloperationen, sportmedizinischen Eingriffen und Rekonstruktionen nach ausgedehnten Tumorresektionen. Die Hauptgefahr nach einer Transplantation besteht in der potenziellen Übertragung klinisch relevanter Infektionserreger. In den mit der Herstellung muskuloskelettaler Gewebetransplantate beauftragten Gewebebanken hat sich daher ein Sicherheitsstufenkonzept etabliert, das aus Spenderauswahl, Labortestung, Gewebegewinnung und -verarbeitung und Qualitätssicherung besteht. Des Weiteren wurden Verfahren entwickelt, die einerseits die biologischen Eigenschaften des Gewebes schützen und andererseits zu einer hohen Infektionssicherheit führen. In Deutschland werden hierfür validierte chemische und thermische Inaktivierungsverfahren mit Erfolg angewendet. Die ordnungsgemäße Qualitätssicherung gemäß Arzneimittel- und Wirkstoffherstellungsverordnung (AMWHV) und Transplantationsgesetz(TPG)-Gewebeverordnung sichert die gesetzeskonforme Arbeit von Gewebebanken.
Abstract
The transplantation of musculoskeletal tissues is widely used in orthopedics, sports medicine, traumatology and reconstruction after extensive tumor resection. The main risk after transplantation is the potential transmission of clinically relevant pathogens. Tissue banks have therefore established a safety level approach for the manufacture of musculoskeletal tissue transplants which includes donor selection, laboratory testing, tissue procurement, tissue processing and quality assurance. In addition, procedures have been developed to protect the biological properties of the tissue and to guarantee a high microbiological safety. In Germany validated chemical and thermal inactivation procedures have been successfully applied. A correct quality assurance in accordance with the Pharmaceuticals and Active Substances Production Act (AMWHV) and Transplantation Act (TPG) for tissue regulation ensures that tissue banks work within the law.
Literatur
Brosig H, Jacker HJ, Borchert HH et al (2005) Sufficient penetration of peracetic acid into drilled human femoral heads. Cell Tissue Bank 6(3):231–237
Campbell DG, Li P (1999) Sterilisation of HIV with irradiation: relevance to infected bone allografts. Aust N Z J Surg 69:517–521
CDC, Center for Disease Control and Prevention (1988) Transmission of HIV through bone transplantation: case report and public health recommendations. MMWR Morb Mortal Wkly Rep 37:597–599
CDC, Center for Disease Control and Prevention (2002) Update: allograft-associated bacterial infections. MMWR Morb Mortal Wkly Rep 51(10):207–210
CDC, Center for Disease Control and Prevention (2003) Hepatitis C virus transmission from an antibody-negative organ and tissue donor. MMWR Morb Mortal Wkly Rep 52(13):273–276
Conrad EU, Gretch DR, Obermeyer KR et al (1995) Transmission of the hepatitis-C virus by tissue transplantation. J Bone Joint Surg [Am] 77(2):214–224
Fideler BM, Vangness T, Moore T et al (1994) Effects of gamma irradiation on the human immunodeficiency virus. A study in frozen human bone-patellar ligament-bone grafts obtained from infected cadavera. J Bone Joint Surg [Am] 76(7):1032–1035
Günther KP, Scharf HP, Pesch HJ et al (1996) Osteointegration lösungsmittelkonservierter Knochentransplantate im Tiermodell. Osteologie 5(1):4–12
Hernigou P, Gras G, Marinello G et al (2000) Influence of irradiation on the risk of transmission of HIV in bone grafts obtained from appropriately screened donors and followed by radiation sterilization. Cell Tissue Bank 1(4):279–289
Hoburg AT, Keshlaf S, Schmidt T et al (2010) Effect of electron beam irradiation on biomechanical properties of patellar tendon allografts in anterior cruciate ligament reconstruction. Am J Sports Med 38(6):1134–1140
Hoburg A, Keshlaf S, Schmidt T et al (2011) Fractionation of high-dose electron beam irradiation of BPTB grafts provides significantly improved viscoelastic and structural properties compared to standard gamma irradiation. Knee Surg Sports Traumatol Arthrosc 19(11):1955–1961
Kainer MA, Linden JV, Whaley DN et al (2004) Clostridium infections associated with musculoskeletal-tissue allografts. N Engl J Med 350(25):2564–2571
Knaepler H, Garrel T von, Gotzen L (1994) Untersuchungen zur Desinfektion und Sterilisation allogener Knochentransplantate. Hefte Z Unfallchir 235:1–101
Liu JW, Chao LH, Su LH et al (2002) Experience with a bone bank operation and allograft bone infection in recipients at medical centre in southern Taiwan. J Hosp Infect 50:293–297
Lord CF, Gebhardt MC, Tomford WW, Mankin HJ (1988) Infection in bone allograft. Incidence, nature, and treatment. J Bone Joint Surg [Am] 70(3):369–376
Nielsen HT, Larsen S, Andersen M, Ovesen O (2001) Bone bank service in Odense, Denmark. Audit of the first ten years with bone banking at the department of orthopaedics, Odense University Hospital. Cell Tissue Bank 2:179–183
Pruss A, Göbel UB, Pauli G et al (2003) Peracetic acid-ethanol treatment of allogeneic avital bone tissue transplants – a reliable sterilization method. Ann Transplant 8(2):34–42
Pruss A, Kao M, Gohs U et al (2002) Effects of gamma irradiation on human cortical bone transplants contaminated with enveloped and non-enveloped viruses. Biologicals 30:205–213
Pruss A, Seibold M, Benedix F et al (2003) Validation of the ‚Marburg bone bank system‘ for thermodesinfection of allogenic femoral head transplants using selected bacteria, fungi, and spores. Biologicals 31:287–294
Pruss A, Caspari G, Krüger DH et al (2010) Tissue donation and virus safety: more nucleic acid amplification testing is needed. Transpl Infect Dis 12(5):375–386
Sanzén L, Carlsson A (1997) Transmission of human T-cell lymphotrophic virus type 1 by a deep-frozen bone allograft. Acta Orthop Scand 68(1):72–74
Scheffler SU, Gonnermann J, Kamp J et al (2008) Remodeling of ACL allografts is inhibited by peracetic acid sterilization. Clin Orthop Relat Res 466(8):1810–1818
Schratt HE, Regel G, Kiesewetter B et al (1996) HIV-Infektion durch kältekonservierte Knochentransplantate. Unfallchirurg 99:679–684
Sclafani AP, McCormick SA, Cocker R (2002) Biophysical and microscopic analysis of homologous dermal and fascial materials for facial anesthetic and reconstructive uses. Arch Facial Plast Surg 4(3):164–171
Shutkin NM (1954) Homologous-serum hepatitis following the use of refrigerated bone-bank bone. J Bone Joint Surg 36-A:160–162
Simonds RJ, Holmberg SD, Hurwitz RL et al (1992) Transmission of human immunodeficiency virus type 1 from a seronegative organ and tissue donor. N Engl J Med 326(11):726–732
Sutherland AG, Raafat A, Yates P et al (1997) Infection associated with the use of allograft bone from the North East Scotland Bone Bank. J Hosp Infect 35(3):215–222
Tomford WW, Starkweather RJ, Goldman MH (1981) A study of the clinical incidence of infection in the use of banked allograft bone. J Bone Joint Surg [Am] 63(2):244–248
Tomford WW, Thongphasuk J, Mankin HJ et al (1990) Frozen musculoskeletal allografts. A study of the clinical incidence and causes of infection associated with their use. J Bone Joint Surg [Am] 72(8):1137–1143
Versen R von, Heider H, Kleemann I et al (1992) Chemische Sterilisation biologischer Implantate mit einer Kombinationsmethode. In: Pesch HJ, Stöß H, Kummer B (Hrsg) Osteologie aktuell. Springer, Berlin Heidelberg New York
Interessenkonflikt
Der korrespondierende Autor weist auf folgende Beziehung hin: er erhält ein Beraterhonorar von der Firma telos H + V Marburg.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pruß, A., Kalus, U. Sicherheitsstandards bei der Verwendung muskuloskelettaler Allografts. Arthroskopie 25, 30–35 (2012). https://doi.org/10.1007/s00142-011-0677-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00142-011-0677-5